HPHA — Heidelberg Pharma AG Share News
0.000.00%
Last trade - 00:00- €120.70m
- €147.30m
- €1.46m
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty
Brief: Heidelberg Pharma Expects FY EBIT Between EUR -19 Mln And EUR -22 Mln
Brief: Heidelberg Pharma AG: Announces Updated Guidance
Brief: Redhill Announces First Patient Enrolled In US Government-Supported COVID-19 Study
Brief: Heidelberg Pharma Announces Receipt of Cash Payment after Closing of Royalty Purchase Agreement with Healthcare Royalty
Brief: Heidelberg Pharma: Progress Into Cohort 6 With Proprietary Atac Candidate HDP-101 In Phase I/Iia Multiple Myeloma Study
Brief: Heidelberg Pharma AG: 9M Earnings Per Share 0.34 EUR Vs 0.39 EUR Year Ago
Brief: Heidelberg Pharma: Partner Takeda Reached Development Milestone
Brief: Heidelberg Pharma AG Sees FY22 Sales And Other Income Between EUR 18.5 Mln And EUR 20.5 Mln
Brief: Heidelberg Pharma Announces Conclusion Of License Agreement With Partner Takeda To Develop An Antibody Targeted Amanitin Conjugate
Brief: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure
Europe Research Roundup: Carrefour, Handelsbanken, Swedbank
Brief: Heidelberg Pharma H1 2022 Sales Revenue At EUR 11.9 Mln
Brief: Heidelberg Pharma Announces It Receives With Huadong All Approvals For The Announced Transaction From The Authorities And Plan Capital Measure
Brief: Heidelberg Pharma Q1 Net Loss At EUR 7.2 Mln
Brief: Heidelberg Pharma FY Net Loss Widens To EUR -26.1 Mln
Brief: Heidelberg Pharma And Huadong Announce Strategic Partnership
Brief: Huadong Medicine In Strategic Cooperation With Heidelberg Pharma AG